| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |